Every enterprise healthcare practice I talk to has the same story.

They bought a patient outreach tool two or three years ago. Maybe two tools. One handles no-show follow-ups and cancellation rebooking. Another handles digital intake and scheduling. Both were solid pitches. Both checked the boxes. And both are now sitting in that uncomfortable middle ground where they're not broken enough to replace, but not good enough to expand.

I've been selling healthcare technology for 25 years. And if there's one thing I've learned about competitive displacement, it's this: you almost never win by being better on paper. You win by being the kind of partner that people want to build with — not the kind of vendor they've learned to work around.

The Inertia Problem

Legacy vendors in healthcare have an enormous structural advantage: switching costs.

Healthcare organizations don't change technology lightly. An outreach platform is wired into scheduling workflows, EMR configurations, provider templates, and staff routines. Ripping it out means retraining staff, reconfiguring integrations, managing a transition period where things inevitably get worse before they get better, and explaining to leadership why the thing they just bought two years ago is being replaced.

That's a lot of organizational pain. And for most practices, "good enough" beats "better but painful to get to." So the incumbent doesn't have to be great. They just have to be tolerable. And most of them are exactly that — tolerable. This is the moat that legacy vendors rely on. Not product superiority. Not client loyalty. Inertia.

What Displacement Actually Looks Like

We recently onboarded a large enterprise practice that had been running two separate vendors for patient outreach. One handled no-show and cancellation rebooking. The other handled digital intake and new patient scheduling.
Both had been in place for years. Both were "fine."
The practice made the decision to consolidate onto a single AI-powered platform. Within weeks of deployment, the results were unambiguous:

• 73% more cancelled appointments rebooked than the previous vendor was capturing

• 76% more no-show patients successfully re-engaged

• 13% more total appointments booked than the intake platform had been generating

Those numbers matter. In a large specialty practice, each of those percentages translates directly to recovered revenue — appointments that would have otherwise gone unfilled, patients who would have otherwise fallen off the schedule.

But the metric that told me the most about whether this displacement would stick wasn't in any dashboard.

The Quote That Changed My Perspective

A few weeks into deployment, the operations lead — the person who manages daily scheduling across dozens of locations — said something that stopped me: "If the old system moved an appointment wrong, we would have just turned it off. With yours, we're trying to tune it and make it better."

I've been in enterprise sales long enough to know that this is the single most important signal you can get from a client. When something goes wrong with a legacy vendor, the default response is avoidance. Turn it off. Work around it. Go back to the manual process. The trust was never deep enough to survive a failure.

When something goes wrong with a true partner, the default response is collaboration. Let's figure out what happened. Let's tune it. Let's make it better.

That distinction — between a tool people tolerate and a tool people invest in — is the entire ballgame in enterprise healthcare sales.

Why This Matters for How You Sell

If you're building a commercial strategy around displacing incumbents in healthcare, here's what I'd challenge you to think about:

Stop leading with feature comparisons. The buyer already knows their current vendor's limitations. They don't need you to point them out. What they need is confidence that switching will be worth the pain. That's an outcomes conversation, not a features conversation.
Lead with results from practices like theirs. When I tell a 200-location specialty practice that a similar-sized practice saw 73% more cancellations rebooked after consolidating vendors, that's not a product pitch. That's a business case. Specificity builds credibility in a way that product demos never will.
Understand that displacement is a trust problem, not a technology problem. The practice isn't evaluating whether your AI is better than their current tool. They're evaluating whether you're worth the risk of change. Every interaction before the contract — how you scope, how you demo, how you handle objections — is either building or eroding that trust.
Make the transition painless. This is where most displacement attempts fail. The product might be better, but the migration is brutal, the onboarding takes months, and the practice spends the first 90 days worse off than they were before. If you can get a practice live in 4-6 weeks with measurable results, you've eliminated the single biggest objection to switching.

The Real Competitive Advantage

I've led commercial teams through three major exits in healthcare technology. At Epocrates, we displaced the print PDR by being more useful at the point of care — not by being a better book, but by being a better workflow. At Jumo Health, we displaced legacy patient education by proving that engagement-driven content produced measurable comprehension gains, not just impressions. At WebMD/Medscape, we built a mobile business that didn't compete with existing desktop products — it created a category that made the old approach feel obsolete.

The pattern is consistent: you don't displace incumbents by being incrementally better at what they already do. You displace them by reframing what success looks like.

In patient outreach, success isn't calls placed or messages sent. It's appointments booked. Revenue recovered. Patients who actually get the care they need.

When you can prove that — with real numbers, from real practices — the incumbent's inertia starts to crack. And when the ops team starts tuning your system instead of working around it, you know the displacement is permanent.

Legacy vendors survive on inertia. Partners earn their place every day.

Rick Scorzetti is the Chief Commercial Officer at Parakeet Health, an AI-powered patient access platform for large specialty practices. He has 25 years of experience in healthcare technology sales leadership, including three major exits at Epocrates, WebMD/Medscape, and Jumo Health. Connect with him on LinkedIn.